‘Walking in Memphis’ singer Marc Cohn reveals years-long Parkinson’s battle: ‘Needed time to process’
Marc Cohn is walking in his truth. The 65-year-old singer, whose “Walking in Memphis” single took the world by storm in the ...
cirm.ca.gov1d
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...
Rolling Out2d
A breakthrough in Parkinson’s disease detection
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
ACADIA Pharmaceuticals' SWOT analysis: stock outlook amid mixed product performance
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...
Can mold exposure cause Parkinson’s disease? Colorado family hopes to prove 'landmark' legal case
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...
MedPage Today4d
Mold and Parkinson's? Cannabis and Brain Function; Women and Long COVID Risk
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...